WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $1.00M, a 140.96% increase from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $415.00K, a 88.55% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $3.63M, a 94.74% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.86M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $1.00M 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $1.00M 10-Q · filed 2025-11-06 | $363.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.00M 10-Q · filed 2026-08-06 | $363.00K derived: sum of 3 quarters · filed 2026-08-06 | $983.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-07 | $363.00K derived: sum of 2 quarters · filed 2026-05-07 | $983.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.97M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$17.00K derived: sum of 2 quarters · filed 2026-03-12 | $970.00K derived: sum of 3 quarters · filed 2026-03-12 | $415.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.61M derived: sum of 2 quarters · filed 2025-11-06 | $1.05M 10-Q · filed 2025-11-06 | $823.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $987.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $432.00K 10-Q · filed 2025-08-07 | $203.00K derived: sum of 3 quarters · filed 2025-08-07 | $2.24M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$555.00K 10-Q · filed 2025-05-08 | -$784.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.26M derived: sum of 3 quarters · filed 2025-05-08 | -$632.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.81M derived: sum of 2 quarters · filed 2025-03-28 | -$77.00K derived: sum of 3 quarters · filed 2025-03-28 | $3.63M 10-K · filed 2025-03-28 |
| 2023-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $152.00K derived: sum of 2 quarters · filed 2024-11-06 | $3.85M 10-Q · filed 2024-11-06 | $3.46M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.81M 10-Q · filed 2024-08-07 | $1.42M derived: sum of 3 quarters · filed 2024-08-07 | $1.61M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $3.70M 10-Q · filed 2024-05-08 | $3.30M derived: sum of 2 quarters · filed 2024-05-08 | $3.50M derived: sum of 3 quarters · filed 2024-05-08 | $2.86M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$201.00K derived: sum of 2 quarters · filed 2024-03-13 | -$846.00K derived: sum of 3 quarters · filed 2024-03-13 | $1.86M 10-K · filed 2024-03-13 |
| 2022-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$447.00K derived: sum of 2 quarters · filed 2023-11-08 | $2.26M 10-Q · filed 2023-11-08 | $2.26M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.06M 10-Q · filed 2023-08-09 | $2.06M derived: sum of 3 quarters · filed 2023-08-09 | $2.06M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.71M 10-Q · filed 2023-05-10 | $2.71M derived: sum of 2 quarters · filed 2023-05-10 | $2.71M derived: sum of 3 quarters · filed 2023-05-10 | $2.59M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | -$120.00K derived: sum of 3 quarters · filed 2023-03-29 | -$14.15M 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$120.00K derived: sum of 2 quarters · filed 2022-11-09 | -$14.15M 10-Q · filed 2022-11-09 | -$231.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$14.15M 10-Q · filed 2022-08-10 | -$231.00K derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$14.03M 10-Q · filed 2022-05-12 | -$111.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $13.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $13.86M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$54.00K 10-Q · filed 2021-11-10 | |||
| 2017-12-31 | -$39.25K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$4.26K derived: sum of 2 quarters · filed 2018-03-15 | -$32.45K derived: sum of 3 quarters · filed 2018-03-15 | -$4.16K 10-K · filed 2018-03-15 |
| 2017-09-30 | $34.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $6.79K derived: sum of 2 quarters · filed 2017-11-13 | $35.09K 10-Q · filed 2017-11-13 | $30.13K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-06-30 | -$28.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $107.00 10-Q · filed 2017-08-10 | -$4.85K derived: sum of 3 quarters · filed 2018-05-15 | -$309.00 derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | $28.30K 10-Q · filed 2018-05-15 | $23.34K derived: sum of 2 quarters · filed 2018-05-15 | $27.88K derived: sum of 3 quarters · filed 2018-05-15 | -$22.61K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$4.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$416.00 derived: sum of 2 quarters · filed 2018-03-15 | -$50.90K derived: sum of 3 quarters · filed 2018-03-15 | -$114.36K 10-K · filed 2018-03-15 |
| 2016-09-30 | $4.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$45.94K derived: sum of 2 quarters · filed 2017-11-13 | -$109.40K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$50.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$113.94K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$63.46K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |